Neuropeptide Y and JO 1784, a selective sigma ligand, alter intestinal ion transport through a common, haloperidol-sensitive site.
Rivière
P J
PJ
Department of Pharmacology, University of Arizona Health Sciences Center, Tucson 85724.
Pascaud
X
X
Junien
J L
JL
Porreca
F
F
D000818:Animals; D002934:Cinnamates / Q000494:pharmacology*; D003521:Cyclopropanes / Q000494:pharmacology*; D006220:Haloperidol / Q000494:pharmacology*; D066298:In Vitro Techniques; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000187:drug effects; D007473:Ion Channels / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D016202:N-Methylaspartate / Q000378:metabolism; D009478:Neuropeptide Y / Q000494:pharmacology*; D011957:Receptors, Opioid / Q000378:metabolism*; D017465:Receptors, Opioid, delta
D002934:Cinnamates; D003521:Cyclopropanes; D007473:Ion Channels; D009478:Neuropeptide Y; D011957:Receptors, Opioid; D017465:Receptors, Opioid, delta; D016202:N-Methylaspartate; D006220:Haloperidol; C065310:igmesine